Harel Insurance Investments & Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-197
| Closed | -$118K | – | 841 |
|
|
2021
Q2 | $118K | Buy |
+197
| New | +$118K | ﹤0.01% | 622 |
|
|
2019
Q1 | – | Sell |
-4,500
| Closed | -$438K | – | 530 |
|
|
2018
Q4 | $438K | Buy |
+4,500
| New | +$438K | 0.03% | 113 |
|
|
2018
Q3 | – | Sell |
-2,200
| Closed | -$273K | – | 532 |
|
|
2018
Q2 | $273K | Sell |
2,200
-1,000
| -31% | -$124K | 0.01% | 168 |
|
|
2018
Q1 | $357K | Buy |
+3,200
| New | +$357K | 0.02% | 164 |
|
|
2016
Q3 | – | Sell |
-69
| Closed | -$8K | – | 693 |
|
|
2016
Q2 | $8K | Buy |
+69
| New | +$8K | ﹤0.01% | 582 |
|